---
title: "Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286465472.md"
description: "Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News"
datetime: "2026-05-14T12:40:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286465472.md)
  - [en](https://longbridge.com/en/news/286465472.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286465472.md)
---

# Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News

Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News

### Related Stocks

- [RNA.US](https://longbridge.com/en/quote/RNA.US.md)

## Related News & Research

- [Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RNA Stock News](https://longbridge.com/en/news/283429396.md)
- [Bioxytran says Phase 2 trial of ProLectin-M drives SARS-CoV-2 viral load below detection by day seven](https://longbridge.com/en/news/294811633.md)
- [High-Risk Warning for Investors in Palvella Therapeutics Securities](https://longbridge.com/en/news/294921758.md)
- [Palvella Therapeutics CEO joins Canaccord Genuity Growth Conference fireside chat](https://longbridge.com/en/news/294958978.md)
- [Defence Therapeutics names Amie Phinney CEO, Plouffe becomes executive chairman](https://longbridge.com/en/news/294782728.md)